semaglutide compounding fda news New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass of "semaglutide" takes effect Safe use of compounded GLP

C., Moro, P

Common Side Effects Discomfort, redness, or swelling at the injection site Less Common Side Effects Itching Difficulty swallowing Lightheadedness Flushed skin Headache Fatigue Restlessness Avoid Sermorelin If You: Are allergic to Sermorelin or any of its ingredients Are pregnant or nursing Have active cancer Precautions Routine monitoring of growth hormone levels, blood glucose, and overall health is advised during use

Artificial sweeteners do not raise blood sugar levels and do not interfere directly with how Mounjaro works

Retatrutide holds no MHRA or EMA marketing authorisation

Research indicates that the activation of GLP-1R can alter the polarization of microglia, shifting them from a proinflammatory (M1) phenotype to an anti-inflammatory (M2) phenotype (Qian et al., 2022)